Expertise in
3
conditions

Takayuki Sugiyama

Hamamatsu, JP 
Expertise in
3
conditions
Hamamatsu, JP 

Overview

Takayuki Sugiyama practices practicing medicine in Hamamatsu, Japan.

Mr. Sugiyama is highly rated in 3 conditions, according to our data. His clinical expertise encompasses Renal Cell Carcinoma (RCC), Prostate Cancer, Bladder Cancer, Nephrectomy, and Prostatectomy.

He is actively involved in clinical research, co-authoring 87 peer reviewed articles and participating in 2 clinical trials.

Gender

Male

Locations

Hamamatsu, Japan
Other Locations
Tokyo, Japan
Yamanashi, Japan
Higashi, Japan

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

2 Clinical Trials

A Phase 2/3, Randomized, Double-Blind, Placebo-Controlled Study of Abiraterone Acetate Plus Prednisone With or Without Abemaciclib in Patients With Metastatic Castration-Resistant Prostate Cancer
A Phase 2/3, Randomized, Double-Blind, Placebo-Controlled Study of Abiraterone Acetate Plus Prednisone With or Without Abemaciclib in Patients With Metastatic Castration-Resistant Prostate Cancer
Enrollment Status: Active_not_recruiting
Publish Date: August 07, 2026
Intervention Type: Drug
Study Drugs: Abemaciclib, Abiraterone Acetate, Prednisone
Study Phase: Phase 2/Phase 3
CYCLONE 3: A Phase 3, Randomized, Double-Blind, Placebo-Controlled Study of Abemaciclib in Combination With Abiraterone Plus Prednisone in Men With High-Risk Metastatic Hormone-Sensitive Prostate Cancer
CYCLONE 3: A Phase 3, Randomized, Double-Blind, Placebo-Controlled Study of Abemaciclib in Combination With Abiraterone Plus Prednisone in Men With High-Risk Metastatic Hormone-Sensitive Prostate Cancer
Enrollment Status: Active_not_recruiting
Publish Date: July 01, 2026
Intervention Type: Drug
Study Phase: Phase 3
View 1 Less Clinical Trial

87 Total Publications

Clinical Anthropometry in Male Infertility: Differences Between Men With and Without Klinefelter Syndrome.
Clinical Anthropometry in Male Infertility: Differences Between Men With and Without Klinefelter Syndrome.
Journal: Cureus
Published: December 09, 2025

Frequently Asked Questions about Takayuki Sugiyama

Is Takayuki Sugiyama a top-rated expert for Renal Cell Carcinoma (RCC)?

MediFind is an objective health platform that identifies experts based on real-world data. Takayuki Sugiyama is classified as an Advanced expert for Renal Cell Carcinoma (RCC), meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.

Does Takayuki Sugiyama participate in research or clinical trials?

Yes. Takayuki Sugiyama has published 87 articles and abstracts on conditions like Renal Cell Carcinoma (RCC). You can view a list of Takayuki Sugiyama's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Mr. Sugiyama's expertise for a condition
ConditionClose
      View All 12 Experienced Conditions
      Want to save this expert for later?
      Sign Up
      Not sure about your diagnosis?
      Check Your Symptoms
       
       
       
       
      Learn about our expert tiers
      Learn More
      Are you the provider on this profile?
      Claim Profile